CASTELLUM INC (CTM)

US14838T2042 - Common Stock

0.1587  0 (-1.06%)

After market: 0.1575 0 (-0.76%)

Fundamental Rating

2

CTM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 84 industry peers in the IT Services industry. Both the profitability and financial health of CTM have multiple concerns. CTM does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

CTM had negative earnings in the past year.
In the past year CTM had a positive cash flow from operations.

1.2 Ratios

CTM's Return On Assets of -59.23% is on the low side compared to the rest of the industry. CTM is outperformed by 92.68% of its industry peers.
With a Return On Equity value of -144.50%, CTM is not doing good in the industry: 84.15% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -59.23%
ROE -144.5%
ROIC N/A
ROA(3y)-43.17%
ROA(5y)N/A
ROE(3y)-91.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 40.74%, CTM is in the better half of the industry, outperforming 64.63% of the companies in the same industry.
CTM's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.76%
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

CTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CTM has been increased compared to 1 year ago.
CTM has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -1.33, we must say that CTM is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.33, CTM is doing worse than 89.02% of the companies in the same industry.
CTM has a debt to FCF ratio of 28.79. This is a negative value and a sign of low solvency as CTM would need 28.79 years to pay back of all of its debts.
CTM has a Debt to FCF ratio of 28.79. This is comparable to the rest of the industry: CTM outperforms 42.68% of its industry peers.
CTM has a Debt/Equity ratio of 0.79. This is a neutral value indicating CTM is somewhat dependend on debt financing.
CTM's Debt to Equity ratio of 0.79 is on the low side compared to the rest of the industry. CTM is outperformed by 67.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 28.79
Altman-Z -1.33
ROIC/WACCN/A
WACC11.35%

2.3 Liquidity

A Current Ratio of 1.11 indicates that CTM should not have too much problems paying its short term obligations.
CTM has a Current ratio of 1.11. This is in the lower half of the industry: CTM underperforms 69.51% of its industry peers.
A Quick Ratio of 1.11 indicates that CTM should not have too much problems paying its short term obligations.
CTM has a Quick ratio of 1.11. This is in the lower half of the industry: CTM underperforms 68.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11

3

3. Growth

3.1 Past

CTM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.52%.
The Revenue has been growing slightly by 7.24% in the past year.
Measured over the past years, CTM shows a very strong growth in Revenue. The Revenue has been growing by 50.25% on average per year.
EPS 1Y (TTM)-5.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.43%
Revenue 1Y (TTM)7.24%
Revenue growth 3Y50.25%
Revenue growth 5YN/A
Sales Q2Q%-7.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y61.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

CTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

65.85% of the companies in the same industry are more expensive than CTM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.73
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CTM!.
Industry RankSector Rank
Dividend Yield N/A

CASTELLUM INC

NYSEARCA:CTM (11/22/2024, 8:04:02 PM)

After market: 0.1575 0 (-0.76%)

0.1587

0 (-1.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.90M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -59.23%
ROE -144.5%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 40.74%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-5.52%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y61.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.24%
Revenue growth 3Y50.25%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y